News & Press Archive
CMBI News 2013 - 2014
December 4, 2014:
The Austrian Science Fund, FWF, decided to fund the CMBI-coordinated SFB F44 (cell signaling in chronic CNS disorders) for a second funding period of 4 years … more »
December 2, 2014:
New therapeutic strategies for improved pain management - Mariana Spetea and her group from the Institute of Pharmacy, Pharmaceutical Chemistry report on new opioid ligands that favorably activate the G protein signaling pathway over the β-arrestin2 pathway as potential effective pain therapeutics with fewer side effects… more »
November 24, 2014:
In July 2014 the Austrian Science Fund, FWF, decided to fund a new reseach project of Eduard Stefan.
August 12, 2014:
Scientists from the Scripps Research Institute and the CMBI report on inhibition of major cancer driver Myc … more »
July 24, 2014:
In July 2014 the Austrian Science Fund, FWF, decided to fund a new reseach project of Pia Aanstad … more »
June 24, 2014:
Scientists of the University of Ulm in collaboration with CMBI scientists at the University of Innsbruck (Pharmacology, Institute of Pharmacy) discovered a new molecular mechanisms that may shed new light on the neurodegenerative process underlying Parkinson' disease. Both groups are part of the research network "cell signaling in chronic CNS disorders" established at the Innsbruck universities … more »
May 28, 2015:
In March 2015 the Austrian Science Fund, FWF, decided to fund two new reseach projects of CMBI members (Markus Ganzera, Klaus Liedl) … more »
December 12, 2013:
Eduard Stefan from the Institute of Biochemistry was awarded the Prize of the City of Innsbruck … more »
October 17, 2013:
B. Grubeck-Loebenstein from the Research Institute for Biomedical Aging Research was awarded the Tiroler Landespreis fuer Wissenschaft 2013 … more »
August 19, 2013:
How riboswitches are tuned for gene regulation has been disclosed by CMBI chemists … more »
August 13, 2013:
Researchers from the CMBI helped to identify aberrant calcium channel activity as a molecular switch responsible for the development of adrenal adenomas. Such adenomas can produce excess aldosterone, leading to hypertension in humans. The European research consortium led by University of Cambridge scientist Morris Brown, has recently published their findings in Nature Genetics … more »
July 12, 2013:
Chlorophyll Breakdown Branches Out - key step identified by scientists from the Institute of Organic Chemistry ... more »
May 23, 2013:
Scientists from the Institute of Biochemistry in Innsbruck discovered a unique mechanism which is based on binary protein-protein interactions and which explains cross talk between critically regulated signaling cascades ... more »
March 20, 2013:
Functional Antivitamin B12 generated by M. Ruetz and B. Kraeutler from the Institute of Organic Chemistry … more »
view forthcoming »
CMBI News 2008 - 2010 »
CMBI News 2011 - 2012 »
CMBI News 2015 - 2016 »
CMBI News 2017 - 2018 »